[Federal Register Volume 88, Number 11 (Wednesday, January 18, 2023)]
[Notices]
[Pages 2928-2930]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-00807]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-23-1282]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled ``The Performance Measures Project: Improving 
Performance Measurement and Monitoring by CDC Programs'' to the Office 
of Management and Budget (OMB) for review and approval. CDC previously 
published a ``Proposed Data Collection Submitted for Public Comment and 
Recommendations'' notice on July 25, 2022 to obtain comments from the 
public and affected agencies. CDC received one comment related to the 
previous notice. This notice serves to allow an additional 30 days for 
public and affected agency comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the

[[Page 2929]]

use of appropriate automated, electronic, mechanical, or other 
technological collection techniques or other forms of information 
technology, e.g., permitting electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570. Comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct 
written comments and/or suggestions regarding the items contained in 
this notice to the Attention: CDC Desk Officer, Office of Management 
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 
395-5806. Provide written comments within 30 days of notice 
publication.

Proposed Project

    The Performance Measures Project: Improving Performance Measurement 
and Monitoring by CDC Programs (OMB Control No. 0920-1282, Exp. 1/31/
2023)--Revision--Office of the Director for Policy and Strategy 
(OADPS), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    Each year, approximately 75% of the CDC's congressionally 
appropriated funding goes to extramural organizations, including state 
and local partners, via contracts, grants, and, most commonly, 
cooperative agreements. The availability of funding for grants and 
cooperative agreements is announced through a Notice of Funding 
Opportunity (NOFO). CDC awards up to 100 new, non-research NOFOs each 
year (each funded for one to five years). These awards may have only a 
few funded recipients or more than 50, such as when a CDC program 
provides funding to all states and territories. Monitoring and 
reporting of program performance is required of any non-federal entity 
receiving federal funds under 45 CFR 75.342; ``The non-federal entity 
must monitor its activities under federal awards to assure compliance 
with applicable federal requirements and performance expectations are 
being achieved''.
    CDC's Program Performance and Evaluation Office (PPEO) provides 
technical assistance to CDC programs and funding recipients with the 
immediate goal of monitoring progress and the long-term goals of 
improving performance and maximizing public health impact. Greater 
public health impact can be achieved by the development of performance 
measures and monitoring plans that are customized to the goals outlined 
in each NOFO. PPEO therefore provides consultations for the development 
of NOFO-specific performance measures and the development of each 
NOFO's logic model (i.e., a graphic depiction of the relationship 
between the funded activities and the intended effects or outcomes of 
those activities in the short, medium, and/or long term).
    PPEO has also developed templates that can be further customized by 
CDC/ATSDR programs participating in the Performance Measures Project 
(PMP). These templates include a sample ``Performance Measure Technical 
Specification Instrument'' and a sample ``Performance Measure Reporting 
Instrument.'' After the templates are finalized by PPEO and the CDC/
ATSDR program, the templates are completed by the recipients of CDC/
ATSDR funding.
    CDC requests OMB approval to continue information collection for 
the PMP, with changes. Individual collection requests submitted under 
this Generic approval will continue to include the tailored forms and a 
supplementary template that provides a description of program purpose 
and the estimated burden of information collection. CDC proposes minor 
changes to the template that clarify: (i) the calendar year(s) in which 
each program will collect information; (ii) the frequency of 
information collection (annual, semi-annual, quarterly, or other); and 
(iii) total burden requested for up to three years of approval. These 
clarifications are needed because the majority of awards are for multi-
year projects, and the frequency of reporting may vary according to 
program-specific factors.
    In addition, a number of changes to the PMP Generic Clearance 
reflect expanded technical assistance that PPEO provides to CDC 
programs. The CDC program eligibility to participate in PMP will be 
expanded as follows:
    (1) Given the recent increase in grants and other funding 
mechanisms used at CDC to enhance programmatic flexibility, PMP 
eligibility will expand to include all available funding mechanisms for 
eligible programs (i.e., activities funded through grants, cooperative 
agreements, or contracts).
    (2) PPEO is providing increasing technical assistance to 
international programs. Eligibility will expand to include both 
domestic and international programs.
    (3) Many CDC programs are operating under the HHS COVID-19 
Emergency PRA waiver. This Emergency Waiver is expected to be 
discontinued. PMP will prioritize transitioning CDC program performance 
measure data collection from the Emergency Waiver to PMP.
    (4) Some CDC programs are developing common performance metrics 
across multiple public health initiatives. PMP will prioritize cross-
NOFO collaboration with these programs to increase efficiency.
    (5) As CDC/ATSDR programs transition back to normal function after 
the COVID-19 pandemic, there has been increased interest in PMP. The 
revision will increase the estimated number of new programs that may 
participate from 25 programs to 40 programs.
    (6) CDC proposes changes to the GenIC Request Template that clarify 
the calendar years in which each program's customized templates will be 
administered, and total burden hours for the entire period of 
information collection. The template will adopt the standard burden 
table format utilized throughout CDC/ATSDR which provides greater 
clarity with respect to the frequency of information collection 
(annual, semi-annual, quarterly, or other). These changes will improve 
recordkeeping for the 0920-1282 generic and improve CDC/PPEO's ability 
to monitor capacity and usage of the generic, while also providing 
increased flexibility for CDC/ATSDR programs to describe their data 
collection plans.
    Finally, in addition to requesting increased PMP capacity 
(respondents and burden hours) to cover expanded eligibility and 
anticipated increases in PMP utilization, CDC is also requesting 
additional capacity to ensure seamless continuation of GenIC data 
collections that were previously approved but have not been completed.
    The requested total estimated annualized burden will increase from 
35,000 hours to 97,049 hours. OMB approval is requested for three 
years. There are no costs to respondents other than their time.

[[Page 2930]]



                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                                      Average
                                                                     Number of       Number of      burden per
          Type of respondents                   Form name            responses     responses per   response (in
                                                                                    respondent        hours)
----------------------------------------------------------------------------------------------------------------
CDC Award Recipients (new GENICs).....  Performance Measures               1,750               1              40
                                         Project Information
                                         Collection Tool.
CDC Award Recipients (continuation of   Performance Measures               2,192               1          740/60
 previously approved GENICs).            Project Information
                                         Collection Tool.
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2023-00807 Filed 1-17-23; 8:45 am]
BILLING CODE 4163-18-P